Eicosanoids are 20-carbon fatty acids, where the usual focus is the polyunsaturated analogue arachidonic acid and its metabolites. Arachidonic acid is thought primarily to derive from phospholipase A2 action on membrane phosphatidylcholine, and may be re-cycled to form phospholipid through conjugation with coenzyme A and subsequently glycerol derivatives. Oxidative metabolism of arachidonic acid is conducted through three major enzymatic routes: cyclooxygenases; lipoxygenases and cytochrome P450-like epoxygenases, particularly CYP2J2. Isoprostanes are structural analogues of the prostanoids (hence the nomenclature D-, E-, F-isoprostanes and isothromboxanes), which are produced in the presence of elevated free radicals in a non-enzymatic manner, leading to suggestions for their use as biomarkers of oxidative stress. Molecular targets for their action have yet to be defined.

Toggle GtoImmuPdb View Expand all nodesCollapse all nodes

* Key recommended reading is highlighted with an asterisk

Aïd S, Bosetti F. (2011) Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie, 93 (1): 46-51. [PMID:20868723]

Cathcart MC, O'Byrne KJ, Reynolds JV, O'Sullivan J, Pidgeon GP. (2012) COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Biochim. Biophys. Acta, 1825 (1): 49-63. [PMID:22015819]

Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD. (2014) Therapeutic implications of the prostaglandin pathway in Alzheimer's disease. Biochem. Pharmacol., 88 (4): 565-72. [PMID:24434190]

Davidson J, Rotondo D, Rizzo MT, Leaver HA. (2012) Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism. Br. J. Pharmacol., 166 (4): 1193-210. [PMID:22364602]

Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. (2011) Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid Res., 50 (1): 115-31. [PMID:20970452]

* Durand T, Bultel-Poncé V, Guy A, El Fangour S, Rossi JC, Galano JM. (2011) Isoprostanes and phytoprostanes: Bioactive lipids. Biochimie, 93 (1): 52-60. [PMID:20594988]

* Floyd CN, Ferro A. (2014) Mechanisms of aspirin resistance. Pharmacol. Ther., 141 (1): 69-78. [PMID:23993980]

Félétou M, Huang Y, Vanhoutte PM. (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br. J. Pharmacol., 164 (3): 894-912. [PMID:21323907]

* Haeggström JZ, Funk CD. (2011) Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev., 111 (10): 5866-98. [PMID:21936577]

* Korotkova M, Jakobsson PJ. (2014) Persisting eicosanoid pathways in rheumatic diseases. Nat Rev Rheumatol, 10 (4): 229-41. [PMID:24514915]

* Krieg P, Fürstenberger G. (2014) The role of lipoxygenases in epidermis. Biochim. Biophys. Acta, 1841 (3): 390-400. [PMID:23954555]

Majed BH, Khalil RA. (2012) Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol. Rev., 64 (3): 540-82. [PMID:22679221]

Muñoz-Garcia A, Thomas CP, Keeney DS, Zheng Y, Brash AR. (2013) The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier. Biochim. Biophys. Acta,  [Epub ahead of print]. [PMID:24021977]

O'Banion MK. (2010) Prostaglandin E2 synthases in neurologic homeostasis and disease. Prostaglandins Other Lipid Mediat., 91 (3-4): 113-7. [PMID:19393332]

* Rodríguez M, Domingo E, Municio C, Alvarez Y, Hugo E, Fernández N, Sánchez Crespo M. (2014) Polarization of the innate immune response by prostaglandin E2: a puzzle of receptors and signals. Mol. Pharmacol., 85 (1): 187-97. [PMID:24170779]

Rouzer CA, Marnett LJ. (2011) Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Chem. Rev., 111 (10): 5899-921. [PMID:21923193]

Salvado MD, Alfranca A, Haeggström JZ, Redondo JM. (2012) Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. Trends Mol Med, 18 (4): 233-43. [PMID:22425675]

Saper CB, Romanovsky AA, Scammell TE. (2012) Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat. Neurosci., 15 (8): 1088-95. [PMID:22837039]

* Smith WL, Urade Y, Jakobsson PJ. (2011) Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev., 111 (10): 5821-65. [PMID:21942677]

Sostres C, Lanas A. (2011) Gastrointestinal effects of aspirin. Nat Rev Gastroenterol Hepatol, 8 (7): 385-94. [PMID:21647198]

* Tai HH, Chi X, Tong M. (2011) Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Prostaglandins Other Lipid Mediat., 96 (1-4): 37-40. [PMID:21763448]